Drug class
Selective beta-1 adrenergic receptor antagonist with partial beta-2 agonist activity; antihypertensive
Mechanism of action
Blocks cardiac beta-1 adrenergic receptors while exhibiting partial beta-2 agonist activity, reducing heart rate and myocardial workload and producing peripheral vasodilatory effects.
General use cases
- Treatment of hypertension and selected angina symptoms in countries where celiprolol is authorised
- Used in some jurisdictions for vascular Ehlers-Danlos syndrome (vEDS) under specialist protocols; this is not a universal product-approved indication
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
